Correlation between color doppler flow imaging and microvessel density, and the Nottingham prognostic index in breast cancer patients

doi:10.3877/cma.j.issn.1674-0793.2017.05.010

Abstract

Abstract:

Objective

To investigate the correlation between color doppler flow imaging (CDFI) and microvessel density (MVD), and the Nottingham prognostic index (NPI) in breast cancer patients.

Methods

One hundred patients with breast carcinoma, who had undergone CDFI and surgery, were involved in this retrospective study from September 2011 to December 2013 in the First Peoples’ Hospital of Lianyungang. CDFI was divided into 4 levels: absent (grade 0), minimal (grade 1), moderate (grade 2), and marked (grade 3). The MVD was measured by immunohistochemical staining of their formalin-fixed paraffin-embedded tissue with monocloal antibody CD34. NPI was calculated as: NPI= 0.2×tumor size (cm) + grade (Ⅰ-Ⅲ) + lymph node score (1-3).

Results

Blood signal grades were positively correlated with MVD (F=26.997, P<0.001) and NPI (Spearman r=0.555, P<0.001). With the increasing of CDFI, the number of MVD and value of NPI increased gradually.

Conclusion

CDFI may be useful as a prognostic indicator for patients with breast carcinoma.

Key words: Breast neoplasms, Ultrasonography, doppler, color

Yang Liu, Xingtian Wang. Correlation between color doppler flow imaging and microvessel density, and the Nottingham prognostic index in breast cancer patients[J]. Chinese Archives of General Surgery(Electronic Edition), 2017, 11(05): 336-339.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2017.05.010

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2017/V11/I05/336

Figures/Tables 2

References 12

[1]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 [J]. CA Cancer J Clin, 2015, 65(1):5-29.
[2]	Shen ZY, Hu B, Wu MF. Correlation between blood flow signal of color flow imaging and Nottingham prognostic index in patients with breast carcinoma [J]. Breast Care, 2012, 7(2):126-130.
[3]	Uzzan B, Nicolas P, Cucherat M, et al. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis[J]. Cancer Res, 2004, 64(9):2941-2955.
[4]	吕宝军，殷恒讳，曾庆安, 等. EpoR在浸润性乳腺癌中的表达及与细胞增殖和微血管密度的关系[J/CD]. 中华普通外科学文献(电子版), 2010, 4(5):428-431.
[5]	Kwatra A, Aggarwal D, Gupta R, et al. Correlation of various histopathologic prognostic factors with Nottingham prognostic index and microvessel density in invasive breast carcinoma: a study of 100 cases[J]. Indian J Cancer, 2015, 52(1):110-113.
[6]	Van Belle V, Van Calster B, Brouckaert O, et al. Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis[J]. J Clin Oncol, 2010, 28(27):4129-4134.
[7]	Adler DD, Carson PL, Rubin JM, et al. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings[J]. Ultrasound Med Biol, 1990, 16(6):553-559.
[8]	Weidner N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol, 1995, 147(1):9-19.
[9]	Galea MH, Blamey RW, Elston CE, et al. The Nottingham Prognostic Index in primary breast cancer[J]. Breast Cancer Res Treat, 1992, 22(3):207-219.
[10]	Fuksa L, Micuda S, Grim J, et al. Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy[J]. Cancer Invest, 2012, 30(9):663-678.
[11]	龚凤球，陈小俊，姚典业,等. 乳腺癌患者对乳房重建手术认同度及其相关因素的调查研究[J/CD]. 中华普通外科学文献(电子版), 2017, 11(3):213-216.
[12]	Wang Y, Dan HJ, Fan JH, et al. Evaluation of the correlation between colour power Doppler flow imaging and vascular endothelial growth factor in breast cancer [J]. J Int Med Res, 2010, 38(3):1077-1083.

[1]	Yaping Jia, Shu'e Zeng. Ultrasound and pathological characteristics of breast metaplastic carcinoma containing squamous cell carcinoma components [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 844-848.
[2]	Wei Tang, Rongquan He, Suning Huang. Application of deep learning in imaging for diagnosis, treatment and prognosis prediction of breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 323-328.
[3]	Xia Kang, Hao Tian, Jin Qian, Yuan Gao, Hongming Miao, Xiaowei Qi. Osteorin attenuates osteolysis during bone metastasis of cancers through inhibiting osteoclastogenesis [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 329-339.
[4]	Xiaoli Yi, Shasha Hu, Yan Zhang. Impact of HER-2 low expression on response of neoadjuvant chemotherapy and prognosis in breast cancer patients [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 340-346.
[5]	Jie Shi, Yuntao Li, Haiyan Gao. Prognosis of node-positive luminal A breast cancer patients with neoadjuvant and adjuvant chemotherapy and influencing factors [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 353-361.
[6]	Jiaxuan Liu, Binghe Xu. Annual advancement of clinical research on breast cancer in China [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 259-265.
[7]	Chengcai Yao, Changchun Liu, Wenjian Huang, Ming Chen. Single-port non-lipolysis fluorescence-guided laparoscopy for axillary lymph node biopsy in early breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 266-271.
[8]	Bohui Shi, Xiping Ding, Lian Wang, Rong Li, Pingli Guo, Jing Qi, Yao Chen, Na Hao, Yu Ren. Summary of best evidences for prevention and treatment of subcutaneous seroma after breast cancer surgery [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 277-284.
[9]	Yaping Wang, Jing Fan, Niuniu Hou, Rui Ling. Clinical significance of tumor-infiltrating lymphocytes in HER-2-positive early breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(04): 203-209.
[10]	Wenbo Gao, Ming Li, Yunhao Zhang. Prognostic value and clinical significance of advanced lung cancer inflammation index in patients with triple negative breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(04): 210-217.
[11]	Qinqin Zhang, Junnan Wang, Houmin Lin, Ying Wu, Yuemei Tan, Mingzhou Li, Junfei Jin, Ningxia Wang, Yong Hong. Bioinformatics analysis of differential expression and clinical significance of complement 3 in breast cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(04): 271-277.
[12]	Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[13]	Zhiming Li, Chenming Guo, Xiaochen Zhuang, Xueqin Hou, Junxi Gao. Comparative study of qualitative and quantitative indicators of contrast-enhanced ultrasound in early breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 639-643.
[14]	Hongbo Qu, Fang Zhu, Zhe Xu, Nan Wu, Jianhuai He, Xianming Wang. Application of subclavian lymph node dissection through intermuscular approach in locally advanced breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 510-513.
[15]	Shan Chen, Zhiqiang Hu, Yueming Zhang, Ding Tang, Meng Li, Shuai Zhao. Expression of Orai1 and Orai3 in breast cancer and their correlation with pathological indexes [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 514-517.

Please choose a citation manager

Content to export